Running on Empty or is Horizon Pharma PLC (HZNP) Refueling?

Shares of Horizon Pharma PLC (HZNP) are moving on volatility today 1.59% or 0.22 from the open. The NASDAQ listed company saw a recent bid of 14.05 and 3291460 shares have traded hands in the session.

Investors often struggle with keeping their emotions in check when approaching the stock market. New investors can have a tendency to sell off winners too quick as well as hold onto losers for way too long. Some will argue that it is never a bad thing to take profits when they are on the table, but this can leave the investor with a large amount of regret if the stock continues to surge after selling. On the other end, investors may hold onto losers for way too long hoping for a bounce back. Holding out for better days can lead to even more exaggerated losses that can leave the investor with an even bigger feeling of regret. Battling to keep emotions separated from important investing decisions can be a big plus for investors over the long haul. Of course, this idea is easier to preach and much harder to follow.

Turning to Return on Assets or ROA, Horizon Pharma PLC (HZNP) has a current ROA of -4.53. This is a profitability ratio that measures net income generated from total company assets during a given period. This ratio reveals how quick a company can turn it’s assets into profits. In other words, the ratio provides insight into the profitability of a firm’s assets. The ratio is calculated by dividing total net income by the average total assets.

A higher ROA compared to peers in the same industry, would suggest that company management is able to effectively generate profits from their assets. Similar to the other ratios, a lower number might raise red flags about management’s ability when compared to other companies in a similar sector.

Now let’s take a look at how the fundamentals are stacking up for Horizon Pharma PLC (HZNP). Fundamental analysis takes into consideration market, industry and stock conditions to help determine if the shares are correctly valued. Horizon Pharma PLC currently has a yearly EPS of -2.70. This number is derived from the total net income divided by shares outstanding. In other words, EPS reveals how profitable a company is on a share owner basis.

Another key indicator that can help investors determine if a stock might be a quality investment is the Return on Equity or ROE. Horizon Pharma PLC (HZNP) currently has Return on Equity of -12.95. ROE is a ratio that measures profits generated from the investments received from shareholders.

In other words, the ratio reveals how effective the firm is at turning shareholder investment into company profits. A company with high ROE typically reflects well on management and how well a company is run at a high level. A firm with a lower ROE might encourage potential investors to dig further to see why profits aren’t being generated from shareholder money.

Another ratio we can look at is the Return on Invested Capital or more commonly referred to as ROIC. Horizon Pharma PLC (HZNP) has a current ROIC of -6.05. ROIC is calculated by dividing Net Income – Dividends by Total Capital Invested. Similar to ROE, ROIC measures how effectively company management is using invested capital to generate company income. A high ROIC number typically reflects positively on company management while a low number typically reflects the opposite. 

Investors may have a solid plan in place to start trading the equity market. Sometimes, these plans never get to be fully realized because of the lack of discipline in the early stages. When a new investor goes into the red right out the gate, there can be a tendency to take on too much risk trying to get back to even. This may result in the investor abandoning the plan and making too many unreasonable trades with exorbitant expectations. Finding the self control to not get discouraged with early losses may help the investor stick to the plan and eventually start achieving longer-term goals. 

Leave a Comment